Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Akorn Inc (NQ: AKRX)
2.955 USD  -0.035 (-1.17%)
Streaming Delayed Price  /  Updated: 11:35 AM EDT, Apr 26, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 382,120
Open 2.980
Bid (Size) 2.950 (19)
Ask (Size) 2.960 (20)
Prev. Close 2.990
Today's Range 2.870 - 2.990
52wk Range 2.670 - 19.65
Shares Outstanding 125,258,615
Dividend Yield N/A
Performance
YTD
-15.09%
-15.09%
1 Month
-10.73%
-10.73%
3 Month
-27.22%
-27.22%
6 Month
-55.09%
-55.09%
1 Year
-78.16%
-78.16%
Top News
More News
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akorn, Inc.
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the April 22, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Akorn, Inc. (“Akorn”... Read More
from GlobeNewswire News Releases
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Akorn, Inc. (“Akorn” or “the Company”) (NASDAQ: AKRX) for violations of... Read More
from GlobeNewswire News Releases
More News
Read More
Glancy Prongay & Murray LLP Files a Securities Class Action Notifying Investors of Expanded Class Period (AKRX)
from Business Wire News Releases
Block & Leviton LLP Reminds Shareholders of Important Deadlines: AKRX, SYNH, INGN, BPI
from GlobeNewswire News Releases
Akorn Receives FDA Approval for Loteprednol Etabonate Ophthalmic Suspension, 0.5%
from GlobeNewswire News Releases
Akorn Receives FDA Approval for Fluticasone Propionate Nasal Spray USP, 50 mcg per spray (OTC)
from GlobeNewswire News Releases
APRIL 22 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Akorn, Inc. – AKRX
from GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline – AKRX
from GlobeNewswire News Releases
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akorn, Inc.
from GlobeNewswire News Releases
AKORN APRIL 22nd DEADLINE: Rosen Law Firm Reminds Akorn, Inc. Investors of Important Deadline in Securities Class Action Lawsuit Filed by the Firm – AKRX
from GlobeNewswire News Releases
Innovus Pharma Announces FDA Approval of New ANDA for Supply of FlutiCare®
from Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.